{"transactions":[{"id":768631,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:04:02.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":100240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 33,414 shares will vest on February 26, 2027; 33,413 shares will vest on February 26, 2028; and 33,413 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"date","element":"transactionDate","label":"F6","text":"The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 33,414 shares will vest on February 26, 2027; 33,413 shares will vest on February 26, 2028; and 33,413 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 33,414 shares will vest on February 26, 2027; 33,413 shares will vest on February 26, 2028; and 33,413 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":100240,"derivative":{"underlying":"Common Stock","underlying_shares":100240},"source":{"system":"sec-edgar","filing":"0001771498-26-000005","document":"wk-form4_1779393839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000005/wk-form4_1779393839.xml","form_type":"4"}},{"id":768630,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2026-05-21T20:04:02.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":123760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting schedule for the options granted on May 20, 2026 was as follows: 41,254 shares will vest on February 26, 2027; 41,253 shares will vest on February 26, 2028; 41,253 shares will vest on February 26, 2029."}],"balance_after":123760,"derivative":{"exercise_price":1.73,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":123760},"source":{"system":"sec-edgar","filing":"0001771498-26-000005","document":"wk-form4_1779393839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000005/wk-form4_1779393839.xml","form_type":"4"}},{"id":768629,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:04:02.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":false,"shares":28296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":56592,"derivative":{"underlying":"Common Stock","underlying_shares":28296},"source":{"system":"sec-edgar","filing":"0001771498-26-000005","document":"wk-form4_1779393839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000005/wk-form4_1779393839.xml","form_type":"4"}},{"id":768628,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-21T20:04:02.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":12306,"price":1.23,"value":15136.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":111021,"source":{"system":"sec-edgar","filing":"0001771498-26-000005","document":"wk-form4_1779393839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000005/wk-form4_1779393839.xml","form_type":"4"}},{"id":768627,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-21T20:04:02.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":true,"shares":28296,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":123327,"source":{"system":"sec-edgar","filing":"0001771498-26-000005","document":"wk-form4_1779393839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000005/wk-form4_1779393839.xml","form_type":"4"}},{"id":775630,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-18T20:08:07.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":false,"shares":17744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17744},"source":{"system":"sec-edgar","filing":"0001771498-26-000004","document":"wk-form4_1779134885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000004/wk-form4_1779134885.xml","form_type":"4"}},{"id":775629,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:08:07.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":7717,"price":1.3,"value":10032.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":95031,"source":{"system":"sec-edgar","filing":"0001771498-26-000004","document":"wk-form4_1779134885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000004/wk-form4_1779134885.xml","form_type":"4"}},{"id":775628,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:08:07.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":true,"shares":17744,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."}],"balance_after":102748,"source":{"system":"sec-edgar","filing":"0001771498-26-000004","document":"wk-form4_1779134885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000004/wk-form4_1779134885.xml","form_type":"4"}},{"id":859346,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-05T21:55:11.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":78760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 78,760 restricted stock units granted on March 4, 2026 was as follows: 26,254 shares will vest on February 26, 2027; 26,253 shares will vest on February 26, 2028; and 26,253 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 78,760 restricted stock units granted on March 4, 2026 was as follows: 26,254 shares will vest on February 26, 2027; 26,253 shares will vest on February 26, 2028; and 26,253 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 78,760 restricted stock units granted on March 4, 2026 was as follows: 26,254 shares will vest on February 26, 2027; 26,253 shares will vest on February 26, 2028; and 26,253 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":78760,"derivative":{"underlying":"Common Stock","underlying_shares":78760},"source":{"system":"sec-edgar","filing":"0001771498-26-000003","document":"wk-form4_1772747707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000003/wk-form4_1772747707.xml","form_type":"4"}},{"id":859345,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2026-03-05T21:55:11.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":97240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 97,240 options granted on March 4, 2026 was as follows: 32,414 shares will vest on February 26, 2027; 32,413 shares will vest on February 26, 2028; 32,413 shares will vest on February 26, 2029."}],"balance_after":97240,"derivative":{"exercise_price":1.73,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":97240},"source":{"system":"sec-edgar","filing":"0001771498-26-000003","document":"wk-form4_1772747707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000003/wk-form4_1772747707.xml","form_type":"4"}},{"id":878012,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:47:50.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":28401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":56800,"derivative":{"underlying":"Common Stock","underlying_shares":28401},"source":{"system":"sec-edgar","filing":"0001771498-26-000002","document":"wk-form4_1772228868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000002/wk-form4_1772228868.xml","form_type":"4"}},{"id":878011,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:47:50.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":18632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":18631,"derivative":{"underlying":"Common Stock","underlying_shares":18632},"source":{"system":"sec-edgar","filing":"0001771498-26-000002","document":"wk-form4_1772228868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000002/wk-form4_1772228868.xml","form_type":"4"}},{"id":878010,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:47:50.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":13657,"price":1.79,"value":24446.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein."}],"balance_after":85004,"source":{"system":"sec-edgar","filing":"0001771498-26-000002","document":"wk-form4_1772228868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000002/wk-form4_1772228868.xml","form_type":"4"}},{"id":878009,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:47:50.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":28401,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":98661,"source":{"system":"sec-edgar","filing":"0001771498-26-000002","document":"wk-form4_1772228868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000002/wk-form4_1772228868.xml","form_type":"4"}},{"id":878008,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:47:50.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":8057,"price":1.79,"value":14422.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":70260,"source":{"system":"sec-edgar","filing":"0001771498-26-000002","document":"wk-form4_1772228868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000002/wk-form4_1772228868.xml","form_type":"4"}},{"id":878007,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:47:50.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":18632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":78317,"source":{"system":"sec-edgar","filing":"0001771498-26-000002","document":"wk-form4_1772228868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000002/wk-form4_1772228868.xml","form_type":"4"}},{"id":1139383,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2025-05-21T20:58:59.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":105262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting schedule for the 105,262 options is as follows: 52,631 shares will vest on May 20, 2027 and 52,631 shares will vest on May 20, 2028."}],"balance_after":105262,"derivative":{"exercise_price":2.13,"expiration_date":"2035-05-20","underlying":"Common Stock","underlying_shares":105262},"source":{"system":"sec-edgar","filing":"0001055726-25-000042","document":"wk-form4_1747861132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000042/wk-form4_1747861132.xml","form_type":"4"}},{"id":1139382,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-05-21T20:58:59.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":84888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units is as follows: 28,296 shares will vest on May 20, 2026; 28,296 shares will vest on May 20, 2027; and 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units is as follows: 28,296 shares will vest on May 20, 2026; 28,296 shares will vest on May 20, 2027; and 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units is as follows: 28,296 shares will vest on May 20, 2026; 28,296 shares will vest on May 20, 2027; and 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":84888,"derivative":{"underlying":"Common Stock","underlying_shares":84888},"source":{"system":"sec-edgar","filing":"0001055726-25-000042","document":"wk-form4_1747861132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000042/wk-form4_1747861132.xml","form_type":"4"}},{"id":1146002,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-05-16T20:08:36.000Z","date":"2025-05-15","kind":"exercise","planned":false,"acquired":false,"shares":17744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units is as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares will vest on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units is as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares will vest on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units is as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares will vest on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."}],"balance_after":17744,"derivative":{"underlying":"Common Stock","underlying_shares":17744},"source":{"system":"sec-edgar","filing":"0001055726-25-000030","document":"wk-form4_1747426107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000030/wk-form4_1747426107.xml","form_type":"4"}},{"id":1146001,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-16T20:08:36.000Z","date":"2025-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":7717,"price":1.95,"value":15048.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":59685,"source":{"system":"sec-edgar","filing":"0001055726-25-000030","document":"wk-form4_1747426107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000030/wk-form4_1747426107.xml","form_type":"4"}},{"id":1146000,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-16T20:08:36.000Z","date":"2025-05-15","kind":"exercise","planned":false,"acquired":true,"shares":17744,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units is as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares will vest on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."}],"balance_after":67402,"source":{"system":"sec-edgar","filing":"0001055726-25-000030","document":"wk-form4_1747426107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000030/wk-form4_1747426107.xml","form_type":"4"}},{"id":1152671,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-05-12T20:39:38.000Z","date":"2025-05-10","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units was as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares vested on May 10, 2025. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units was as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares vested on May 10, 2025. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units was as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares vested on May 10, 2025. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001055726-25-000020","document":"wk-form4_1747082363.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000020/wk-form4_1747082363.xml","form_type":"4"}},{"id":1152670,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-12T20:39:38.000Z","date":"2025-05-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2392,"price":1.8,"value":4305.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":49658,"source":{"system":"sec-edgar","filing":"0001055726-25-000020","document":"wk-form4_1747082363.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000020/wk-form4_1747082363.xml","form_type":"4"}},{"id":1152669,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-12T20:39:38.000Z","date":"2025-05-10","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units was as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares vested on May 10, 2025. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."}],"balance_after":52050,"source":{"system":"sec-edgar","filing":"0001055726-25-000020","document":"wk-form4_1747082363.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000020/wk-form4_1747082363.xml","form_type":"4"}},{"id":1239117,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-28T23:05:39.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":85201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 is as follows: 28,401 shares will vest on February 26, 2026; 28,400 shares will vest on February 26, 2027; and 28,400 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 is as follows: 28,401 shares will vest on February 26, 2026; 28,400 shares will vest on February 26, 2027; and 28,400 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 is as follows: 28,401 shares will vest on February 26, 2026; 28,400 shares will vest on February 26, 2027; and 28,400 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":85201,"derivative":{"underlying":"Common Stock","underlying_shares":85201},"source":{"system":"sec-edgar","filing":"0001055726-25-000003","document":"wk-form4_1740783933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000003/wk-form4_1740783933.xml","form_type":"4"}},{"id":1239116,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2025-02-28T23:05:39.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":105649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting schedule for the 105,649 options is as follows: 52,825 shares vested on February 27, 2025 and 52,824 shares will vest on February 26, 2026."}],"balance_after":105649,"derivative":{"exercise_price":1.94,"exercise_date":"2025-02-27","expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":105649},"source":{"system":"sec-edgar","filing":"0001055726-25-000003","document":"wk-form4_1740783933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000003/wk-form4_1740783933.xml","form_type":"4"}},{"id":1239115,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-28T23:05:39.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":18632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024  is as follows: 18,632 shares vested on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024  is as follows: 18,632 shares vested on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024  is as follows: 18,632 shares vested on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":37263,"derivative":{"underlying":"Common Stock","underlying_shares":18632},"source":{"system":"sec-edgar","filing":"0001055726-25-000003","document":"wk-form4_1740783933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000003/wk-form4_1740783933.xml","form_type":"4"}},{"id":1239114,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-28T23:05:39.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":false,"shares":5852,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 17,557 restricted stock units granted on February 26, 2022 was as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares vested on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 17,557 restricted stock units granted on February 26, 2022 was as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares vested on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 17,557 restricted stock units granted on February 26, 2022 was as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares vested on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5852},"source":{"system":"sec-edgar","filing":"0001055726-25-000003","document":"wk-form4_1740783933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000003/wk-form4_1740783933.xml","form_type":"4"}},{"id":1239113,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-28T23:05:39.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":9088,"price":1.98,"value":17994.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein."}],"balance_after":46550,"source":{"system":"sec-edgar","filing":"0001055726-25-000003","document":"wk-form4_1740783933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000003/wk-form4_1740783933.xml","form_type":"4"}},{"id":1239112,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-28T23:05:39.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":18632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024  is as follows: 18,632 shares vested on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":55638,"source":{"system":"sec-edgar","filing":"0001055726-25-000003","document":"wk-form4_1740783933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000003/wk-form4_1740783933.xml","form_type":"4"}},{"id":1239111,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-28T23:05:39.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2493,"price":1.98,"value":4936.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":37006,"source":{"system":"sec-edgar","filing":"0001055726-25-000003","document":"wk-form4_1740783933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000003/wk-form4_1740783933.xml","form_type":"4"}},{"id":1239110,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-28T23:05:39.000Z","date":"2025-02-26","kind":"exercise","planned":false,"acquired":true,"shares":5852,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 17,557 restricted stock units granted on February 26, 2022 was as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares vested on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":39499,"source":{"system":"sec-edgar","filing":"0001055726-25-000003","document":"wk-form4_1740783933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000003/wk-form4_1740783933.xml","form_type":"4"}},{"id":1514755,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-05-16T20:59:31.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":false,"shares":17745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units is as follows: 17,745 shares vested on May 15, 2024; 17,744 shares will vest on May 15, 2025; and 17,744 shares will vest on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units is as follows: 17,745 shares vested on May 15, 2024; 17,744 shares will vest on May 15, 2025; and 17,744 shares will vest on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units is as follows: 17,745 shares vested on May 15, 2024; 17,744 shares will vest on May 15, 2025; and 17,744 shares will vest on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":35488,"derivative":{"underlying":"Common Stock","underlying_shares":17745},"source":{"system":"sec-edgar","filing":"0001055726-24-000024","document":"wk-form4_1715893155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000024/wk-form4_1715893155.xml","form_type":"4"}},{"id":1514754,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-16T20:59:31.000Z","date":"2024-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":7718,"price":13.07,"value":100874.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":33647,"source":{"system":"sec-edgar","filing":"0001055726-24-000024","document":"wk-form4_1715893155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000024/wk-form4_1715893155.xml","form_type":"4"}},{"id":1514753,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-16T20:59:31.000Z","date":"2024-05-15","kind":"exercise","planned":false,"acquired":true,"shares":17745,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units is as follows: 17,745 shares vested on May 15, 2024; 17,744 shares will vest on May 15, 2025; and 17,744 shares will vest on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":41365,"source":{"system":"sec-edgar","filing":"0001055726-24-000024","document":"wk-form4_1715893155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000024/wk-form4_1715893155.xml","form_type":"4"}},{"id":1519497,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-05-13T20:57:26.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units is as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units is as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units is as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":5500,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001055726-24-000022","document":"wk-form4_1715633831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000022/wk-form4_1715633831.xml","form_type":"4"}},{"id":1519496,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-13T20:57:26.000Z","date":"2024-05-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2392,"price":10.65,"value":25474.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":23620,"source":{"system":"sec-edgar","filing":"0001055726-24-000022","document":"wk-form4_1715633831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000022/wk-form4_1715633831.xml","form_type":"4"}},{"id":1519495,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-05-13T20:57:26.000Z","date":"2024-05-10","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 16,500 restricted stock units is as follows: 5,500 shares vested on May 10, 2023; 5,500 shares vested on May 10, 2024; and 5,500 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":26012,"source":{"system":"sec-edgar","filing":"0001055726-24-000022","document":"wk-form4_1715633831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000022/wk-form4_1715633831.xml","form_type":"4"}},{"id":1613110,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-28T22:09:13.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":55895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units is as follows: 18,632 shares will vest on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units is as follows: 18,632 shares will vest on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units is as follows: 18,632 shares will vest on February 26, 2025; 18,632 shares will vest on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":55895,"derivative":{"underlying":"Common Stock","underlying_shares":55895},"source":{"system":"sec-edgar","filing":"0001055726-24-000005","document":"wk-form4_1709158138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000005/wk-form4_1709158138.xml","form_type":"4"}},{"id":1613109,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2024-02-28T22:09:13.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":69733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The vesting schedule for the 69,733 options is as follows: 17,434 shares vested on February 28, 2024; 17,433 shares will vest on February 28, 2025; 17,433 shares will vest on February 28, 2026; and 17,433 shares will vest on February 28, 2027."}],"balance_after":69733,"derivative":{"exercise_price":8.46,"exercise_date":"2024-02-28","expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":69733},"source":{"system":"sec-edgar","filing":"0001055726-24-000005","document":"wk-form4_1709158138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000005/wk-form4_1709158138.xml","form_type":"4"}},{"id":1613108,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-28T22:09:13.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":5853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 17,557 restricted stock units is as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 17,557 restricted stock units is as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 17,557 restricted stock units is as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":5852,"derivative":{"underlying":"Common Stock","underlying_shares":5853},"source":{"system":"sec-edgar","filing":"0001055726-24-000005","document":"wk-form4_1709158138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000005/wk-form4_1709158138.xml","form_type":"4"}},{"id":1613107,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-28T22:09:13.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":1878,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1878},"source":{"system":"sec-edgar","filing":"0001055726-24-000005","document":"wk-form4_1709158138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000005/wk-form4_1709158138.xml","form_type":"4"}},{"id":1613106,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-28T22:09:13.000Z","date":"2024-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2856,"price":8.16,"value":23304.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (4) herein."}],"balance_after":20512,"source":{"system":"sec-edgar","filing":"0001055726-24-000005","document":"wk-form4_1709158138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000005/wk-form4_1709158138.xml","form_type":"4"}},{"id":1613105,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-28T22:09:13.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":5853,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 17,557 restricted stock units is as follows: 5,852 shares vested on February 26, 2023; 5,853 shares vested on February 26, 2024; and 5,852 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":23368,"source":{"system":"sec-edgar","filing":"0001055726-24-000005","document":"wk-form4_1709158138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000005/wk-form4_1709158138.xml","form_type":"4"}},{"id":1613104,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-28T22:09:13.000Z","date":"2024-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":872,"price":8.16,"value":7115.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":17515,"source":{"system":"sec-edgar","filing":"0001055726-24-000005","document":"wk-form4_1709158138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000005/wk-form4_1709158138.xml","form_type":"4"}},{"id":1613103,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-28T22:09:13.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":1878,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 5,635 restricted stock units was as follows: 1,879 shares vested on February 26, 2022; 1,878 shares vested on February 26, 2023; and 1,878 shares vested on February 26, 2024.  Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Gives effect to a 1-for-12 reverse stock split effected by the Issuer on January 24, 2024."}],"balance_after":18387,"source":{"system":"sec-edgar","filing":"0001055726-24-000005","document":"wk-form4_1709158138.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000005/wk-form4_1709158138.xml","form_type":"4"}},{"id":1889802,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-05-17T20:08:41.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":638800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 638,800 restricted stock units is as follows: 212,934 shares will vest on May 15, 2024; 212,933 shares will vest on May 15, 2025; and 212,933 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was made under the 2016 Omnibus Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 638,800 restricted stock units is as follows: 212,934 shares will vest on May 15, 2024; 212,933 shares will vest on May 15, 2025; and 212,933 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 638,800 restricted stock units is as follows: 212,934 shares will vest on May 15, 2024; 212,933 shares will vest on May 15, 2025; and 212,933 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":638800,"derivative":{"underlying":"Common Stock","underlying_shares":638800},"source":{"system":"sec-edgar","filing":"0001055726-23-000040","document":"wk-form4_1684354107.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000040/wk-form4_1684354107.xml","form_type":"4"}},{"id":1895514,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-05-12T20:12:32.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":false,"shares":66000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares vested on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares vested on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares vested on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":132000,"derivative":{"underlying":"Common Stock","underlying_shares":66000},"source":{"system":"sec-edgar","filing":"0001055726-23-000032","document":"wk-form4_1683922339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000032/wk-form4_1683922339.xml","form_type":"4"}},{"id":1895513,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-12T20:12:32.000Z","date":"2023-05-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":28704,"price":0.81,"value":23250.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":198113,"source":{"system":"sec-edgar","filing":"0001055726-23-000032","document":"wk-form4_1683922339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000032/wk-form4_1683922339.xml","form_type":"4"}},{"id":1895512,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-12T20:12:32.000Z","date":"2023-05-10","kind":"exercise","planned":false,"acquired":true,"shares":66000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares vested on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":226817,"source":{"system":"sec-edgar","filing":"0001055726-23-000032","document":"wk-form4_1683922339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000032/wk-form4_1683922339.xml","form_type":"4"}},{"id":1957215,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-13T21:07:52.000Z","date":"2023-03-11","kind":"exercise","acquired":false,"shares":59737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":59737},"source":{"system":"sec-edgar","filing":"0001055726-23-000012","document":"wf-form4_167874165226829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000012/wf-form4_167874165226829.xml","form_type":"4"}},{"id":1957214,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-13T21:07:52.000Z","date":"2023-03-11","kind":"tax_withholding","acquired":false,"shares":25980,"price":1.13,"value":29357.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":160817,"source":{"system":"sec-edgar","filing":"0001055726-23-000012","document":"wf-form4_167874165226829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000012/wf-form4_167874165226829.xml","form_type":"4"}},{"id":1957213,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-13T21:07:52.000Z","date":"2023-03-11","kind":"exercise","acquired":true,"shares":59737,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":186797,"source":{"system":"sec-edgar","filing":"0001055726-23-000012","document":"wf-form4_167874165226829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000012/wf-form4_167874165226829.xml","form_type":"4"}},{"id":1987911,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2023-02-28T22:44:25.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":836800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The vesting schedule for the 836,800 options is as follows: 209,200 shares vested on February 27, 2023; 209,200 shares will vest on February 26, 2024; 209,200 shares will vest on February 26, 2025; and 209,200 shares will vest on February 26, 2026."}],"balance_after":836800,"derivative":{"exercise_price":1.24,"exercise_date":"2023-02-27","expiration_date":"2033-02-27","underlying":"Common Stock","underlying_shares":836800},"source":{"system":"sec-edgar","filing":"0001055726-23-000007","document":"wf-form4_167762425136925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000007/wf-form4_167762425136925.xml","form_type":"4"}},{"id":1987910,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-28T22:44:25.000Z","date":"2023-02-26","kind":"exercise","acquired":false,"shares":70234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2022, the reporting person was granted 210,700 restricted stock units, vesting as follows: 70,234 shares vested on February 26, 2023; 70,233 shares will vest on February 26, 2024; and 70,233 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2022, the reporting person was granted 210,700 restricted stock units, vesting as follows: 70,234 shares vested on February 26, 2023; 70,233 shares will vest on February 26, 2024; and 70,233 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2022, the reporting person was granted 210,700 restricted stock units, vesting as follows: 70,234 shares vested on February 26, 2023; 70,233 shares will vest on February 26, 2024; and 70,233 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":140466,"derivative":{"underlying":"Common Stock","underlying_shares":70234},"source":{"system":"sec-edgar","filing":"0001055726-23-000007","document":"wf-form4_167762425136925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000007/wf-form4_167762425136925.xml","form_type":"4"}},{"id":1987909,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-02-28T22:44:25.000Z","date":"2023-02-26","kind":"exercise","acquired":false,"shares":22544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":22544,"derivative":{"underlying":"Common Stock","underlying_shares":22544},"source":{"system":"sec-edgar","filing":"0001055726-23-000007","document":"wf-form4_167762425136925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000007/wf-form4_167762425136925.xml","form_type":"4"}},{"id":1987908,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-28T22:44:25.000Z","date":"2023-02-26","kind":"tax_withholding","acquired":false,"shares":32485,"price":1.28,"value":41580.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein."}],"balance_after":127060,"source":{"system":"sec-edgar","filing":"0001055726-23-000007","document":"wf-form4_167762425136925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000007/wf-form4_167762425136925.xml","form_type":"4"}},{"id":1987907,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-28T22:44:25.000Z","date":"2023-02-26","kind":"exercise","acquired":true,"shares":70234,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2022, the reporting person was granted 210,700 restricted stock units, vesting as follows: 70,234 shares vested on February 26, 2023; 70,233 shares will vest on February 26, 2024; and 70,233 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":159545,"source":{"system":"sec-edgar","filing":"0001055726-23-000007","document":"wf-form4_167762425136925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000007/wf-form4_167762425136925.xml","form_type":"4"}},{"id":1987906,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-28T22:44:25.000Z","date":"2023-02-26","kind":"tax_withholding","acquired":false,"shares":9788,"price":1.28,"value":12528.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":89311,"source":{"system":"sec-edgar","filing":"0001055726-23-000007","document":"wf-form4_167762425136925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000007/wf-form4_167762425136925.xml","form_type":"4"}},{"id":1987905,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-28T22:44:25.000Z","date":"2023-02-26","kind":"exercise","acquired":true,"shares":22544,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":99099,"source":{"system":"sec-edgar","filing":"0001055726-23-000007","document":"wf-form4_167762425136925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572623000007/wf-form4_167762425136925.xml","form_type":"4"}},{"id":2275131,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-05-11T21:03:48.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":198000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares will vest on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares will vest on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares will vest on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares will vest on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":198000,"derivative":{"underlying":"Common Stock","underlying_shares":198000},"source":{"system":"sec-edgar","filing":"0001055726-22-000035","document":"wf-form4_165230299527837.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000035/wf-form4_165230299527837.xml","form_type":"4"}},{"id":2275130,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2022-05-11T21:03:48.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":309400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 309,400 options is as follows: 77,350 shares vested on May 10, 2022; 77,350 shares will vest on May 10, 2023; 77,350 shares will vest on May 10, 2024; 77,350 shares will vest on May 10, 2025."}],"balance_after":309400,"derivative":{"exercise_price":2.49,"expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":309400},"source":{"system":"sec-edgar","filing":"0001055726-22-000035","document":"wf-form4_165230299527837.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000035/wf-form4_165230299527837.xml","form_type":"4"}},{"id":2316907,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-28T20:05:46.000Z","date":"2022-03-25","kind":"exercise","acquired":false,"shares":16666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares vested on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares vested on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares vested on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares vested on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":16666},"source":{"system":"sec-edgar","filing":"0001055726-22-000031","document":"wf-form4_164849769330568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000031/wf-form4_164849769330568.xml","form_type":"4"}},{"id":2316906,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-28T20:05:46.000Z","date":"2022-03-25","kind":"tax_withholding","acquired":false,"shares":7247,"price":3.63,"value":26306.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":76555,"source":{"system":"sec-edgar","filing":"0001055726-22-000031","document":"wf-form4_164849769330568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000031/wf-form4_164849769330568.xml","form_type":"4"}},{"id":2316905,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-28T20:05:46.000Z","date":"2022-03-25","kind":"exercise","acquired":true,"shares":16666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares vested on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":83802,"source":{"system":"sec-edgar","filing":"0001055726-22-000031","document":"wf-form4_164849769330568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000031/wf-form4_164849769330568.xml","form_type":"4"}},{"id":2336148,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-14T20:46:18.000Z","date":"2022-03-11","kind":"exercise","acquired":false,"shares":59737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":59737,"derivative":{"underlying":"Common Stock","underlying_shares":59737},"source":{"system":"sec-edgar","filing":"0001055726-22-000022","document":"wf-form4_164729057942435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000022/wf-form4_164729057942435.xml","form_type":"4"}},{"id":2336147,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-14T20:46:18.000Z","date":"2022-03-11","kind":"tax_withholding","acquired":false,"shares":25974,"price":3.22,"value":83636.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":67136,"source":{"system":"sec-edgar","filing":"0001055726-22-000022","document":"wf-form4_164729057942435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000022/wf-form4_164729057942435.xml","form_type":"4"}},{"id":2336146,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-14T20:46:18.000Z","date":"2022-03-11","kind":"exercise","acquired":true,"shares":59737,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":93110,"source":{"system":"sec-edgar","filing":"0001055726-22-000022","document":"wf-form4_164729057942435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000022/wf-form4_164729057942435.xml","form_type":"4"}},{"id":2366338,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-01T23:46:47.000Z","date":"2022-02-26","kind":"grant","acquired":true,"shares":210700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 210,700 restricted stock units is as follows: 70,234 shares will vest on February 26, 2023; 70,233 shares will vest on February 26, 2024; 70,233 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 210,700 restricted stock units is as follows: 70,234 shares will vest on February 26, 2023; 70,233 shares will vest on February 26, 2024; 70,233 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 210,700 restricted stock units is as follows: 70,234 shares will vest on February 26, 2023; 70,233 shares will vest on February 26, 2024; 70,233 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 210,700 restricted stock units is as follows: 70,234 shares will vest on February 26, 2023; 70,233 shares will vest on February 26, 2024; 70,233 shares will vest on February 26, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":210700,"derivative":{"underlying":"Common Stock","underlying_shares":210700},"source":{"system":"sec-edgar","filing":"0001055726-22-000010","document":"wf-form4_164617838486383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000010/wf-form4_164617838486383.xml","form_type":"4"}},{"id":2366337,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock Option","published_at":"2022-03-01T23:46:47.000Z","date":"2022-02-26","kind":"grant","acquired":true,"shares":282300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting schedule for the 282,300 options is as follows: 70,575 shares vested on February 26, 2022; 70,575 shares will vest on February 26, 2023; 70,575 shares will vest on February 26, 2024; 70,575 shares will vest on February 26, 2025."}],"balance_after":282300,"derivative":{"exercise_price":3.22,"exercise_date":"2022-02-26","expiration_date":"2032-02-26","underlying":"Common Stock","underlying_shares":282300},"source":{"system":"sec-edgar","filing":"0001055726-22-000010","document":"wf-form4_164617838486383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000010/wf-form4_164617838486383.xml","form_type":"4"}},{"id":2366336,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-01T23:46:47.000Z","date":"2022-02-26","kind":"exercise","acquired":false,"shares":22545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":45088,"derivative":{"underlying":"Common Stock","underlying_shares":22545},"source":{"system":"sec-edgar","filing":"0001055726-22-000010","document":"wf-form4_164617838486383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000010/wf-form4_164617838486383.xml","form_type":"4"}},{"id":2366335,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-01T23:46:47.000Z","date":"2022-02-26","kind":"tax_withholding","acquired":false,"shares":10764,"price":3.22,"value":34660.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":33373,"source":{"system":"sec-edgar","filing":"0001055726-22-000010","document":"wf-form4_164617838486383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000010/wf-form4_164617838486383.xml","form_type":"4"}},{"id":2366334,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-03-01T23:46:47.000Z","date":"2022-02-26","kind":"exercise","acquired":true,"shares":22545,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,545 shares vested on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,544 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":44137,"source":{"system":"sec-edgar","filing":"0001055726-22-000010","document":"wf-form4_164617838486383.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572622000010/wf-form4_164617838486383.xml","form_type":"4"}},{"id":2672506,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-06-11T20:26:51.000Z","date":"2021-06-09","kind":"sale","acquired":false,"shares":38535,"price":10.01,"value":385735.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $10.00 to $10.06, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":21592,"source":{"system":"sec-edgar","filing":"0001055726-21-000052","document":"wf-form4_162344318899072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000052/wf-form4_162344318899072.xml","form_type":"4"}},{"id":2770918,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-03-26T20:10:07.000Z","date":"2021-03-25","kind":"exercise","acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares will vest on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares will vest on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares will vest on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares will vest on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":16666,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001055726-21-000034","document":"wf-form4_161678939086989.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000034/wf-form4_161678939086989.xml","form_type":"4"}},{"id":2770917,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-26T20:10:07.000Z","date":"2021-03-26","kind":"sale","acquired":false,"shares":4710,"price":8.97,"value":42248.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":60127,"source":{"system":"sec-edgar","filing":"0001055726-21-000034","document":"wf-form4_161678939086989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000034/wf-form4_161678939086989.xml","form_type":"4"}},{"id":2770916,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-26T20:10:07.000Z","date":"2021-03-25","kind":"tax_withholding","acquired":false,"shares":7247,"price":9.06,"value":65657.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":64837,"source":{"system":"sec-edgar","filing":"0001055726-21-000034","document":"wf-form4_161678939086989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000034/wf-form4_161678939086989.xml","form_type":"4"}},{"id":2770915,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-26T20:10:07.000Z","date":"2021-03-25","kind":"exercise","acquired":true,"shares":16667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares vested on March 25, 2021; 16,666 shares will vest on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":72084,"source":{"system":"sec-edgar","filing":"0001055726-21-000034","document":"wf-form4_161678939086989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000034/wf-form4_161678939086989.xml","form_type":"4"}},{"id":2792721,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-03-12T23:32:25.000Z","date":"2021-03-11","kind":"exercise","acquired":false,"shares":59737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":119474,"derivative":{"underlying":"Common Stock","underlying_shares":59737},"source":{"system":"sec-edgar","filing":"0001055726-21-000023","document":"wf-form4_161559192268345.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000023/wf-form4_161559192268345.xml","form_type":"4"}},{"id":2792720,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-12T23:32:25.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":16881,"price":10.06,"value":169822.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Reporting person intends to use the proceeds of this sale to pay taxes resulting from the recent vesting of Restricted Stock Units granted by the issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These transactions were executed in multiple trades at prices ranging from $9.96 to $10.18, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":55417,"source":{"system":"sec-edgar","filing":"0001055726-21-000023","document":"wf-form4_161559192268345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000023/wf-form4_161559192268345.xml","form_type":"4"}},{"id":2792719,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-12T23:32:25.000Z","date":"2021-03-11","kind":"tax_withholding","acquired":false,"shares":25974,"price":10.57,"value":274545.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":72298,"source":{"system":"sec-edgar","filing":"0001055726-21-000023","document":"wf-form4_161559192268345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000023/wf-form4_161559192268345.xml","form_type":"4"}},{"id":2792718,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-03-12T23:32:25.000Z","date":"2021-03-11","kind":"exercise","acquired":true,"shares":59737,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares vested on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":98272,"source":{"system":"sec-edgar","filing":"0001055726-21-000023","document":"wf-form4_161559192268345.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000023/wf-form4_161559192268345.xml","form_type":"4"}},{"id":2830315,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2021-02-27T00:05:05.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":67633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,544 shares will vest on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,545 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,544 shares will vest on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,545 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 67,633 restricted stock units is as follows: 22,544 shares will vest on February 26, 2022; 22,544 shares will vest on February 26, 2023; 22,545 shares will vest on February 26, 2024.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":67633,"derivative":{"underlying":"Common Stock","underlying_shares":67633},"source":{"system":"sec-edgar","filing":"0001055726-21-000011","document":"wf-form4_161438428463289.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000011/wf-form4_161438428463289.xml","form_type":"4"}},{"id":2830314,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock Option","published_at":"2021-02-27T00:05:05.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":104833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 104,833 options is as follows: 26,208 shares vested on February 26, 2021; 26,208 shares will vest on February 26, 2022; 26,208 shares will vest on February 26, 2023; 26,209 shares will vest on February 26, 2024."}],"balance_after":104833,"derivative":{"exercise_price":11.1,"exercise_date":"2021-02-26","expiration_date":"2031-02-26","underlying":"Common Stock","underlying_shares":104833},"source":{"system":"sec-edgar","filing":"0001055726-21-000011","document":"wf-form4_161438428463289.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000011/wf-form4_161438428463289.xml","form_type":"4"}},{"id":2882713,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock Option","published_at":"2021-02-04T00:12:42.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":22376,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":3.62,"exercise_date":"2019-03-25","expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":22376},"source":{"system":"sec-edgar","filing":"0001055726-21-000007","document":"wf-form4_161239754472771.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000007/wf-form4_161239754472771.xml","form_type":"4"}},{"id":2882712,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-02-04T00:12:42.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":5960,"price":15,"value":89400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These transactions were executed in multiple trades at prices ranging from $15.00 to $15.07, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":38535,"source":{"system":"sec-edgar","filing":"0001055726-21-000007","document":"wf-form4_161239754472771.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000007/wf-form4_161239754472771.xml","form_type":"4"}},{"id":2882711,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-02-04T00:12:42.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":22376,"price":15.06,"value":336982.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $15.00 to $15.32, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":44495,"source":{"system":"sec-edgar","filing":"0001055726-21-000007","document":"wf-form4_161239754472771.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000007/wf-form4_161239754472771.xml","form_type":"4"}},{"id":2882710,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-02-04T00:12:42.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":22376,"price":3.62,"value":81001.12,"ownership":{"direct":true},"balance_after":66871,"source":{"system":"sec-edgar","filing":"0001055726-21-000007","document":"wf-form4_161239754472771.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000007/wf-form4_161239754472771.xml","form_type":"4"}},{"id":2890696,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock Option","published_at":"2021-01-30T00:03:13.000Z","date":"2021-01-28","kind":"exercise","acquired":false,"shares":55248,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":122376,"derivative":{"exercise_price":3.62,"exercise_date":"2019-03-25","expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":55248},"source":{"system":"sec-edgar","filing":"0001055726-21-000005","document":"wf-form4_161196497789987.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000005/wf-form4_161196497789987.xml","form_type":"4"}},{"id":2890695,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock Option","published_at":"2021-01-30T00:03:13.000Z","date":"2021-01-27","kind":"exercise","acquired":false,"shares":22376,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":177624,"derivative":{"exercise_price":3.62,"exercise_date":"2019-03-25","expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":22376},"source":{"system":"sec-edgar","filing":"0001055726-21-000005","document":"wf-form4_161196497789987.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000005/wf-form4_161196497789987.xml","form_type":"4"}},{"id":2890694,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-30T00:03:13.000Z","date":"2021-01-28","kind":"sale","acquired":false,"shares":16713,"price":12.04,"value":201224.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"These transactions were executed in multiple trades at prices ranging from $12.00 to $12.10, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":44495,"source":{"system":"sec-edgar","filing":"0001055726-21-000005","document":"wf-form4_161196497789987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000005/wf-form4_161196497789987.xml","form_type":"4"}},{"id":2890693,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-30T00:03:13.000Z","date":"2021-01-28","kind":"exercise","acquired":true,"shares":55248,"price":3.62,"value":199997.76,"ownership":{"direct":true},"balance_after":61208,"source":{"system":"sec-edgar","filing":"0001055726-21-000005","document":"wf-form4_161196497789987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000005/wf-form4_161196497789987.xml","form_type":"4"}},{"id":2890692,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-30T00:03:13.000Z","date":"2021-01-27","kind":"sale","acquired":false,"shares":5960,"price":12.04,"value":71758.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"These transactions were executed in multiple trades at prices ranging from $12.00 to $12.07, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":5960,"source":{"system":"sec-edgar","filing":"0001055726-21-000005","document":"wf-form4_161196497789987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000005/wf-form4_161196497789987.xml","form_type":"4"}},{"id":2890691,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-30T00:03:13.000Z","date":"2021-01-27","kind":"sale","acquired":false,"shares":22376,"price":12.01,"value":268735.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These transactions were executed in multiple trades at prices ranging from $12.00 to $12.09, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected."}],"balance_after":11920,"source":{"system":"sec-edgar","filing":"0001055726-21-000005","document":"wf-form4_161196497789987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000005/wf-form4_161196497789987.xml","form_type":"4"}},{"id":2890690,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2021-01-30T00:03:13.000Z","date":"2021-01-27","kind":"exercise","acquired":true,"shares":22376,"price":3.62,"value":81001.12,"ownership":{"direct":true},"balance_after":34296,"source":{"system":"sec-edgar","filing":"0001055726-21-000005","document":"wf-form4_161196497789987.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572621000005/wf-form4_161196497789987.xml","form_type":"4"}},{"id":3194589,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-03-26T20:10:50.000Z","date":"2020-03-25","kind":"exercise","acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares will vest on March 25, 2021; 16,666 shares will vest on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares will vest on March 25, 2021; 16,666 shares will vest on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares will vest on March 25, 2021; 16,666 shares will vest on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares will vest on March 25, 2021; 16,666 shares will vest on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":33333,"derivative":{"underlying":"Common Stock","underlying_shares":16667},"source":{"system":"sec-edgar","filing":"0001055726-20-000019","document":"wf-form4_158525343157103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000019/wf-form4_158525343157103.xml","form_type":"4"}},{"id":3194588,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-03-26T20:10:50.000Z","date":"2020-03-25","kind":"tax_withholding","acquired":false,"shares":4747,"price":6.68,"value":31709.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein."}],"balance_after":11920,"source":{"system":"sec-edgar","filing":"0001055726-20-000019","document":"wf-form4_158525343157103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000019/wf-form4_158525343157103.xml","form_type":"4"}},{"id":3194587,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2020-03-26T20:10:50.000Z","date":"2020-03-25","kind":"exercise","acquired":true,"shares":16667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 50,000 restricted stock units is as follows: 16,667 shares vested on March 25, 2020; 16,667 shares will vest on March 25, 2021; 16,666 shares will vest on March 25, 2022.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":16667,"source":{"system":"sec-edgar","filing":"0001055726-20-000019","document":"wf-form4_158525343157103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000019/wf-form4_158525343157103.xml","form_type":"4"}},{"id":3213978,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-03-12T20:44:43.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":179211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares will vest on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares will vest on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 179,211 restricted stock units is as follows: 59,737 shares will vest on March 11, 2021; 59,737 shares will vest on March 11, 2022; 59,737 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":179211,"derivative":{"underlying":"Common Stock","underlying_shares":179211},"source":{"system":"sec-edgar","filing":"0001055726-20-000016","document":"wf-form4_158404586490604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572620000016/wf-form4_158404586490604.xml","form_type":"4"}},{"id":3577318,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock Option","published_at":"2019-03-27T20:23:03.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting schedule for the 200,000 options is as follows: 50,000 shares vested on March 25, 2019; 50,000 shares will vest on March 25, 2020; 50,000 shares will vest on March 25, 2021; 50,000 shares will vest on March 25, 2022."}],"balance_after":200000,"derivative":{"exercise_price":3.62,"expiration_date":"2029-03-25","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001055726-19-000025","document":"wf-form4_155371816885809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572619000025/wf-form4_155371816885809.xml","form_type":"4"}}],"next_cursor":"2019-03-27T20:23:03.000000Z,3577318"}